Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-25-116997
Filing Date
2025-05-12
Accepted
2025-05-09 17:40:14
Documents
14
Period of Report
2025-05-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d924910d8ka.htm   iXBRL 8-K/A 64895
2 EX-99.1 d924910dex991.htm EX-99.1 36569
  Complete submission text file 0001193125-25-116997.txt   235823

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA indv-20250508.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE indv-20250508_lab.xml EX-101.LAB 18701
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE indv-20250508_pre.xml EX-101.PRE 11689
16 EXTRACTED XBRL INSTANCE DOCUMENT d924910d8ka_htm.xml XML 4104
Mailing Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE
Business Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE 804-379-1090
INDIVIOR PLC (Filer) CIK: 0001625297 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37835 | Film No.: 25931911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)